(Q34351382)

1 August 2017

title

Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers (English)

1 reference

1 August 2017

1 reference

1 reference

9

Olufunmilayo I Olopade

1 reference

1 August 2017

Angela R Bradbury

1

1 reference

1 August 2017

Comfort N Ibe

2

1 reference

1 August 2017

James J Dignam

3

1 reference

1 August 2017

Shelly A Cummings

4

1 reference

1 August 2017

Marion Verp

5

1 reference

1 August 2017

Melody A White

6

1 reference

1 August 2017

Grazia Artioli

7

1 reference

1 August 2017

Laura Dudlicek

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 March 2008

1 reference

1 August 2017

1 reference

1 August 2017

volume

10

1 reference

1 August 2017

issue

3

1 reference

1 August 2017

page(s)

161-166

1 reference

Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Risk reduction behaviors and provider communication following genetic counseling and BRCA1 mutation testing in an African American kindred.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

"Why take it if you don't have anything?" breast cancer risk perceptions and prevention choices at a public hospital

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Breast cancer screening practices among black, Hispanic, and white women: reassessing differences.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4199586

Effect of Short-Term Hormone Replacement Therapy on Breast Cancer Risk Reduction After Bilateral Prophylactic Oophorectomy in BRCA1 and BRCA2 Mutation Carriers: The PROSE Study Group

6 July 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Prophylactic bilateral salpingo-oophorectomy compared with surveillance in women with BRCA mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Risk-reduction surgery decisions in high-risk women seen for genetic counseling

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Breast cancer risk reduction options: awareness, discussion, and use among women from four ethnic groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2FGIM.0B013E318163487D

Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing

21 January 2018

1 reference

12 December 2020

Surveillance behavior and prophylactic surgery after predictive testing for hereditary breast/ovarian cancer

1 reference

12 December 2020

Genetic testing for a BRCA1 mutation: prophylactic surgery and screening behavior in women 2 years post testing

1 reference

12 December 2020

Changes in health-related behaviours following BRCA 1/2 genetic testing: the case of hormone replacement therapy

1 reference

12 December 2020

Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers

1 reference

12 December 2020

Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing

1 reference

12 December 2020

Risk of breast cancer in carriers of BRCA gene mutations

1 reference

12 December 2020

Laparoscopic management of women with a family history of ovarian cancer

1 reference

12 December 2020

Cancer incidence in a population of Jewish women at risk of ovarian cancer

1 reference

12 December 2020

Qualitative Evaluation of Medical Information Processing Needs of 60 Women Choosing Ovarian Cancer Surveillance or Prophylactic Oophorectomy

1 reference

12 December 2020

Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer

1 reference

12 December 2020

Enhanced counseling for women undergoing BRCA1/2 testing: impact on subsequent decision making about risk reduction behaviors

1 reference

12 December 2020

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

10.1097/GIM.0B013E318163487D

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

1047637451

0 references

Fatcat ID

release_uigq2wjpuzbovpfou2cot7gzby

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uigq2wjpuzbovpfou2cot7gzby

24 November 2022

mapped directly with Wikidata item

PMC publication ID

4199586

1 reference

1 August 2017

1 reference